Search for a doctor

Lewis R. Roberts, M.B., Ch.B., Ph.D.

  1. Gastroenterologist
Request an Appointment

Publications

  1. Espinoza AKS, Chotiprasidhi P, Larson JJ, Roberts LR, Wangensteen KJ. CLO25-087: Low Serum Pseudocholinesterase Level Predicts HCC Mortality As Accurately As the ALBI or MESIAH Score. J Natl Compr Canc Netw. 2025 Mar 28; 23 (3.5)
    View PubMed
  2. Atarere J, Annor E, Bilalaga MM, Egbo O, Gaddipati GN, Vasireddy R, Mensah B, Roberts L. Social media use and the relationship with colorectal cancer screening among foreign-born populations in the United States. Cancer Causes Control. 2025 Mar 18 [Epub ahead of print]
    View PubMed
  3. Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y. Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis. Gastroenterology. 2025 Mar; 168 (3):556-567.e7 Epub 2024 Nov 08
    View PubMed
  4. Putatunda V, Jusakul A, Roberts L, Wang XW. Genetic, Epigenetic, and Microenvironmental Drivers of Cholangiocarcinoma. Am J Pathol. 2025 Mar; 195 (3):362-377 Epub 2024 Nov 10
    View PubMed
  5. Danpanichkul P, Suparan K, Auttapracha T, Tothanarungroj P, Kongarin S, Rakwong K, Tan DJH, Sukphutanan B, Muthiah MD, Tung D, Luo J, Morishita A, Tan EY, Takahashi H, Mousa OY, Lui RN, Noureddin M, Kim D, Harnois DM, Yang JD, Roberts LR, Wallace MB, Wijarnpreecha K. Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021. Mayo Clin Proc. 2025 Feb 10 [Epub ahead of print]
    View PubMed
  6. Roberts LR. Surveillance for Hepatocellular Carcinoma. Clin Liver Dis. 2025 Feb; 29 (1):17-31 Epub 2024 Oct 28
    View PubMed
  7. Cooley MA, Schneider AR, Barr Fritcher EG, Milosevic D, Levy MJ, Bridgeman AR, Martin JA, Petersen BT, Abu Dayyeh BK, Storm AC, Law RJ, Vargas EJ, Garimella V, Zemla T, Jenkins SM, Yin J, Gores GJ, Roberts LR, Kipp BR, Chandrasekhara V. Utility of methylated DNA markers for the diagnosis of malignant biliary strictures. Hepatology. 2025 Feb 1; 81 (2):453-464 Epub 2024 June 21
    View PubMed
  8. Kim K, Zheng Y, Joyce BT, Nannini DR, Wang J, Qu Y, Hawkins CA, Okeke E, Lesi OA, Roberts LR, Gursel DB, Abdulkareem FB, Akanmu AS, Duguru MJ, Davwar P, Nyam DP, Adisa RA, Imade G, Wei JJ, Kocherginsky M, Kim KY, Adeyemo WL, Odeghe E, Wehbe FH, Achenbach C, Sagay A, Ogunsola F, Murphy RL, Hou L. Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV. Hepatol Int. 2024 Dec 20 [Epub ahead of print]
    View PubMed
  9. Tesfay MZ, Zhang Y, Ferdous KU, Taylor MA, Cios A, Shelton RS, Simoes CC, Watters CR, Barro O, Elliott NM, Mustafa B, Chamcheu JC, Graham AL, Washam CL, Alkam D, Gies A, Byrum SD, Giorgakis E, Post SR, Kelly T, Ying J, Moaven O, Chabu CY, Fernandez-Zapico ME, Duda DG, Roberts LR, Govindarajan R, Borad MJ, Cannon MJ, Basnakian AG, Nagalo BM. Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade. Mol Ther Oncol. 2024 Dec 19; 32 (4):200913 Epub 2024 Nov 26
    View PubMed
  10. Danpanichkul P, Suparan K, Tothanarungroj P, Dejvajara D, Rakwong K, Pang Y, Barba R, Thongpiya J, Fallon MB, Harnois D, Lui RN, Wallace MB, Yang JD, Roberts LR, Wijarnpreecha K. Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021. Gut. 2024 Dec 10; 74 (1):26-34
    View PubMed
  11. Nishimura S, Linares JF, L'Hermitte A, Duran A, Cid-Diaz T, Martinez-Ordonez A, Ruiz-Martinez M, Kudo Y, Marzio A, Heikenwalder M, Roberts LR, Diaz-Meco MT, Moscat J. Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma. Mol Cell. 2024 Dec 5; 84 (23):4660-4676.e10 Epub 2024 Oct 17
    View PubMed
  12. Antwi SO, Siaw ADJ, Armasu SM, Frank JA, Yan IK, Ahmed FY, Izquierdo-Sanchez L, Boix L, Rojasti A, Banales JM, Reig M, Stal P, Romero Gomez M, Wangensteen KJ, Singal AG, Roberts LR, Patel T. Genome-wide DNA methylation markers associated with metabolic liver cancer. medRxiv. 2024 Nov 15
    View PubMed
  13. Gunchick V, Wen W, Jia G, Roberts LR, Koshiol J, Shu XO, Zheng W. Dietary intake, obesity, and physical activity in association with biliary tract cancer risk: Results from meta-analyses of individual-level data from prospective cohort studies of 723,326 adults. Int J Cancer. 2024 Nov 15; 155 (10):1721-1730 Epub 2024 June 07
    View PubMed
  14. Aggarwal M, Simadibrata DM, Kipp BR, Prokop LJ, Barr Fritcher EG, Schneider A, Cooley MA, Gores GJ, Eaton J, Roberts LR, Chandrasekhara V. Diagnostic Accuracy Performance of Fluorescence In Situ Hybridization (FISH) for Biliary Strictures: A Systematic Review and Meta-Analysis. J Clin Med. 2024 Oct 28; 13 (21)
    View PubMed
  15. Nartey YA, Yang JD, Zemla TJ, Ayawin J, Asibey SO, El-Kassas M, Bampoh SA, Duah A, Agyei-Nkansah A, Awuku YA, Afihene MY, Yamada H, Yin J, Plymoth A, Roberts LR. GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients. Cancer Res Commun. 2024 Oct 1; 4 (10):2653-2659
    View PubMed
  16. Marsh TL, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler A, Page-Lester S, Tayob N, Srivastava S, Rinaudo JA, Singal AG, Reddy KR, Marrero JA. A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis. Gastroenterology. 2024 Sep 16 Epub 2024 Sept 16
    View PubMed
  17. Nwankwo EC Jr, Guta A, Cao SS, Yang JD, Abdalla A, Taha W, Larson JJ, Yin J, Gores GJ, Cleary SP, Roberts LR. Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018. Cancers (Basel). 2024 Jul 31; 16 (15) Epub 2024 July 31
    View PubMed
  18. Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Liu G, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology. 2024 Jul 1; 80 (1):87-101 Epub 2024 Feb 20
    View PubMed
  19. Webb MJ, Sangsuwannukul T, van Vloten J, Evgin L, Kendall B, Tonne J, Thompson J, Metko M, Moore M, Chiriboga Yerovi MP, Olin M, Borgatti A, McNiven M, Monga SPS, Borad MJ, Melcher A, Roberts LR, Vile R. Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nat Commun. 2024 Jun 27; 15 (1):5442 Epub 2024 June 27
    View PubMed
  20. Jackson LE, Tomlinson JL, Alva-Ruiz R, Gregory LA, Byeon SK, Abdelrahman AM, Mun DG, Grant CW, Fogarty ZC, Wang C, Roberts LR, Graham RP, Borad MJ, Ilyas SI, Gores GJ, Pandey A, Athreya AP, Smoot RL. Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma. JHEP Rep. 2024 Jun; 6 (6):101068 Epub 2024 Mar 18
    View PubMed
  21. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2024 Apr 30; 22(1):400.
    View PubMed
  22. Asumda FZ, Campbell NA, Hassan MA, Fathi R, Vasquez Rico DF, Kiem M, Vang EV, Kim YH, Luo X, O'Brien DR, Buhrow SA, Reid JM, Moore MJ, Ben-Yair VK, Levitt ML, Leiting JL, Abdelrahman AM, Zhu X, Lucien F, Truty MJ, Roberts LR. Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts. Cancers (Basel). 2024 Mar 5; 16 (5) Epub 2024 Mar 05
    View PubMed
  23. Park JE, Nguyen VH, Tsai PC, Toyoda H, Leong J, Guy JE, Yeh ML, Huang CF, Yasuda S, Abe H, Hsu YC, Tseng CH, Liu J, Chen YL, Lin PY, Jun DW, Yoshimaru Y, Ogawa E, Ishigami M, Enomoto M, Tamori A, Uojima H, Wang XZ, Xu Q, Takahashi H, Eguchi Y, Inoue K, Huang DQ, Zhao WJ, Chuang WL, Dai CY, Huang JF, Barnett S, Maeda M, Cheung R, Landis C, Tanaka Y, Roberts LR, Schwartz ME, Kumada T, Yu ML, Nguyen MH. Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response. Aliment Pharmacol Ther. 2024 Mar; 59 (6):742-751 Epub 2024 Jan 03
    View PubMed
  24. Emiloju OE, Yin J, Koubek E, Reid JM, Borad MJ, Lou Y, Seetharam M, Edelman MJ, Sausville EA, Jiang Y, Kaseb AO, Posey JA, Davis SL, Gores GJ, Roberts LR, Takebe N, Schwartz GK, Hendrickson AEW, Kaufmann SH, Adjei AA, Hubbard JM, Costello BA. Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs. 2024 Feb; 42(1):127-135. Epub 2024 Jan 25.
    View PubMed
  25. Martini A, Prasai K, Zemla TJ, Ahmed FY, Elnagar MB, Giama NH, Guzzardo V, Biasiolo A, Fassan M, Yin J, Pontisso P, Roberts LR. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma. Cancers (Basel). 2024 Jan 3; 16 (1) Epub 2024 Jan 03
    View PubMed
  26. Marya NB, Hartley C, Powers PD, Bois MC, Kerr SE, Graham RP, Levy MJ, UMass-Mayo Clinic AI Cytopathology Consortium, Gleeson F, Abu Dayyeh BK, Bofill-Garcia A, Chandrasekhara V, Gores G, Kipp B, Law RJ, Petersen B, Roberts LR, Storm AC, Vargas Valls EJ. Development of a Computer-aided Prediction Tool for Evaluating Brushing Samples of Biliary Strictures. Clin Gastroenterol Hepatol. 2024 Jan; 22 (1):185-187.e3 Epub 2023 Mar 24
    View PubMed
  27. Jorgenson LC, Torbenson MS, Halfdanarson TR, Kankeu Fonkoua LA, Tran NH, Roberts LR, Smoot RL, Goenka AH, Thompson SM. Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes. Front Nucl Med. 2024; 4:1480471 Epub 2024 Nov 27
    View PubMed
  28. Lozada ME, Zhang N, Jin W, Wongjarupong N, Yang JD, Voss MM, Prasai K, Amakye DO, Harmsen WS, Chaudhary S, Bathe OF, Borad MJ, Patel TC, Gores GJ, Therneau TM, Roberts LR. CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation. Am J Gastroenterol. 2023 Dec 1; 118 (12):2173-2183 Epub 2023 Mar 20
    View PubMed
  29. Hassan H, Chakrabarti S, Zemla T, Yin J, Wookey V, Prasai K, Abdellatief A, Katta R, Tran N, Jin Z, Cleary S, Roberts L, Mahipal A. Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection. Eur J Surg Oncol. 2023 Nov; 49 (11):106994 Epub 2023 July 27
    View PubMed
  30. Song Y, Ye T, Roberts LR, Larson NB, Winham SJ. Mendelian randomization in hepatology: A review of principles, opportunities, and challenges. Hepatology. 2023 Oct 24 [Epub ahead of print]
    View PubMed
  31. Reddy KR, McLerran D, Marsh T, Parikh N, Roberts LR, Schwartz M, Nguyen MH, Befeler A, Page-Lester S, Tang R, Srivastava S, Rinaudo JA, Feng Z, Marrero JA. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Gastroenterology. 2023 Oct; 165 (4):1053-1063.e6 Epub 2023 July 08
    View PubMed
  32. Abou-Alfa GK, Afihene M, Capanu M, Li Y, Chou JF, Asombang A, Alatise OI, Bounedjar A, Cunha L, Mekonnen HD, Diop PS, Elwakil R, Ali MM, Ndlovu N, Ndumbalo J, Makondi PT, Tzeuton C, Biachi de Castria T, Agyei-Nkansah AA, Balogun F, Bougouma A, Atipo Ibara BI, Jonas E, Kimani S, Kingham P, Kurrimbukus R, Hammad N, Fouad M, El Baghdady N, Servais Albert Fiacre EB, Sewram V, Spearman CW, Yang JD, Roberts LR, Abdelaziz AO. Africa Guidelines for Hepatocellular Carcinoma Buildup Process. JCO Glob Oncol. 2023 Sep; 9:e2300159
    View PubMed
  33. Antwi SO, Heckman M, White L, Yan I, Sarangi V, Lauer KP, Reddy J, Ahmed F, Veliginti S, Mejias Febres ED, Hatia RI, Chang P, Izquierdo-Sanchez L, Boix L, Rojas A, Banales JM, Reig M, Stal P, Gomez MR, Singal AG, Li D, Hassan MM, Roberts LR, Patel T. Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes. Hum Mol Genet. 2023 Aug 7; 32 (16):2646-2655
    View PubMed
  34. Pappas L, Baiev I, Reyes S, Bocobo AG, Jain A, Spencer K, Le TM, Rahma OE, Maurer J, Stanton J, Zhang K, De Armas AD, Deleon TT, Roth M, Peters MLB, Zhu AX, Boyhen K, VanCott C, Patel T, Roberts LR, Lindsey S, Horick N, Lennerz JK, Iafrate AJ, Goff LW, Mody K, Borad MJ, Shroff RT, Javle MM, Kelley RK, Goyal L. The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. JCO Precis Oncol. 2023 Aug; 7:e2200594
    View PubMed
  35. Spencer K, Pappas L, Baiev I, Maurer J, Bocobo AG, Zhang K, Jain A, De Armas AD, Reyes S, Le TM, Rahma OE, Stanton J, DeLeon TT, Roth M, Peters MLB, Zhu AX, Lennerz JK, Iafrate AJ, Boyhen K, VanCott C, Roberts LR, Lindsey S, Horick N, Goff LW, Mody K, Borad MJ, Shroff RT, Kelley RK, Javle MM, Goyal L. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. J Natl Cancer Inst. 2023 Jul 6; 115 (7):870-880
    View PubMed
  36. Terrault NA, Lok AS, Wahed AS, Ghany MG, Perrillo RP, Fried MW, Wong DK, Khalili M, Lau DTY, Sterling RK, Di Bisceglie AM, Lisker-Melman M, Cooper SL, Chung RT, Patel K, Roberts LR, Belle SH, Janssen HLA, Hepatitis B Research Network. Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. Am J Gastroenterol. 2023 Jul 1; 118 (7):1214-1225 Epub 2022 Dec 23
    View PubMed
  37. Calvisi DF, Boulter L, Vaquero J, Saborowski A, Fabris L, Rodrigues PM, Coulouarn C, Castro RE, Segatto O, Raggi C, van der Laan LJW, Carpino G, Goeppert B, Roessler S, Kendall TJ, Evert M, Gonzalez-Sanchez E, Valle JW, Vogel A, Bridgewater J, Borad MJ, Gores GJ, Roberts LR, Marin JJG, Andersen JB, Alvaro D, Forner A, Banales JM, Cardinale V, Macias RIR, Vicent S, Chen X, Braconi C, Verstegen MMA, Fouassier L, CCA Model Consortium. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance. Nat Rev Gastroenterol Hepatol. 2023 Jul; 20 (7):462-480 Epub 2023 Feb 08
    View PubMed
  38. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2023 Jun 23; 21(1):410.
    View PubMed
  39. Webb MJ, Kottke T, Kendall BL, Swanson J, Uzendu C, Tonne J, Thompson J, Metko M, Moore M, Borad M, Roberts L, Diaz RM, Olin M, Borgatti A, Vile R. Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses. Mol Ther Oncolytics. 2023 Jun 15; 29:129-142 Epub 2023 May 22
    View PubMed
  40. Shi Z, Li Z, Jin B, Ye W, Wang L, Zhang S, Zheng J, Lin Z, Chen B, Liu F, Zhang B, Ding X, Yang Z, Shan Y, Yu Z, Wang Y, Chen J, Chen Q, Roberts LR, Chen G. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin Transl Med. 2023 Jun; 13 (6):e1300
    View PubMed
  41. Wiafe YA, Anyitey-Kokor IC, Nmai RA, Afihene M, Roberts LR. Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference Standard. Cureus. 2023 Jun; 15 (6):e40756 Epub 2023 June 21
    View PubMed
  42. Chhatwal J, Samur S, Yang JD, Roberts LR, Nguyen MH, Ozbay AB, Ayer T, Parikh ND, Singal AG. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study. Hepatol Commun. 2023 Jun 1; 7 (6) Epub 2023 May 18
    View PubMed
  43. Nagalo BM, Zhou Y, Loeuillard EJ, Dumbauld C, Barro O, Elliott NM, Baker AT, Arora M, Bogenberger JM, Meurice N, Petit J, Uson PLS Jr, Aslam F, Raupach E, Gabere M, Basnakian A, Simoes CC, Cannon MJ, Post SR, Buetow K, Chamcheu JC, Barrett MT, Duda DG, Jacobs B, Vile R, Barry MA, Roberts LR, Ilyas S, Borad MJ. Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers. Hepatology. 2023 Jun 01; 77(6):1943-1957. Epub 2022 Oct 11.
    View PubMed
  44. Wiafe YA, Afihene MY, Anto EO, Nmai RA, Amoah-Kumi L, Frimpong J, Dickson FD, Antwi SO, Roberts LR. Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography. J Clin Med. 2023 May 29; 12(11).
    View PubMed
  45. McMahon B, Cohen C, Brown RS Jr, El-Serag H, Ioannou GN, Lok AS, Roberts LR, Singal AG, Block T. Opportunities to address gaps in early detection and improve outcomes of liver cancer. JNCI Cancer Spectr. 2023 May 2; 7 (3)
    View PubMed
  46. Lim YS, Kim WR, Dieterich D, Kao JH, Flaherty JF, Yee LJ, Roberts LR, Razavi H, Kennedy PTF. Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses. 2023 Apr 18; 15 (4)
    View PubMed
  47. Khalili M, Leonard KR, Ghany MG, Hassan M, Roberts LR, Sterling RK, Belle SH, Lok AS, Hepatitis B Research Network. Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America. JAMA Netw Open. 2023 Apr 3; 6 (4):e237018 Epub 2023 Apr 03
    View PubMed
  48. Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX, Dan YY, Roberts LR, Loomba R, Huang DQ. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH. Hepatology. 2023 Apr 1; 77 (4):1150-1163 Epub 2022 Sept 12
    View PubMed
  49. Ochoa-Rios S, Blaschke CRK, Wang M, Peterson KD, DelaCourt A, Grauzam SE, Lewin D, Angel P, Roberts LR, Drake R, Mehta AS. Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma. Cancer Res Commun. 2023 Mar; 3 (3):383-394 Epub 2023 Mar 06
    View PubMed
  50. Long L, Liu X, Petrick J, Liu W, Lee JK, Liao L, Lai MJ, Yang W, Libermann TA, Roberts LR, McGlynn KA, Tabung FK, Zhang X. Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality. JNCI Cancer Spectr. 2023 Mar 1; 7 (2)
    View PubMed
  51. Jacobson JM, Zahrieh D, Strand CA, Cruz-Correa M, Pungpapong S, Roberts LR, Mandrekar SJ, Rodriguez LM, Boyer J, Marrero I, Kraynyak KA, Morrow MP, Sylvester AJ, Pawlicki JM, Gillespie E, Barranco E, Richmond E, Umar A, Weiner DB, Limburg PJ, Cancer Prevention Network. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prev Res (Phila). 2023 Mar 1; 16 (3):163-173
    View PubMed
  52. Pant K, Richard S, Peixoto E, Yin J, Seelig DM, Carotenuto P, Salati M, Franco B, Roberts LR, Gradilone SA. The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth. Cells. 2023 Feb 28; 12 (5)
    View PubMed
  53. Han Y, Byun J, Zhu C, Sun R, Roh JY, Cordell HJ, Lee HS, Shaw VR, Kang SW, Razjouyan J, Cooley MA, Hassan MM, Siminovitch KA, Folseraas T, Ellinghaus D, Bergquist A, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, McGlynn KA, Roberts LR, Amos CI, International PSC Study Group. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis. Nat Commun. 2023 Feb 24; 14 (1):1069
    View PubMed
  54. Brown AM, Kassab I, Massani M, Townsend W, Singal AG, Soydal C, Moreno-Luna L, Roberts LR, Chen VL, Parikh ND. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis. Cancer Med. 2023 Feb; 12 (3):2590-2599 Epub 2022 Aug 09
    View PubMed
  55. Kolluri A, Li D, Li N, Duan Z, Roberts LR, Ho M. Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC. Hepatol Commun. 2023 Feb 1; 7 (2):e0022 Epub 2023 Jan 18
    View PubMed
  56. Duwe L, Munoz-Garrido P, Lewinska M, Lafuente-Barquero J, Satriano L, Hogdall D, Taranta A, Nielsen BS, Ghazal A, Matter MS, Banales JM, Aldana BI, Gao YT, Marquardt JU, Roberts LR, Oliveira RC, Koshiol J, O'Rourke CJ, Andersen JB. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells. J Hepatol. 2023 Feb; 78 (2):364-375 Epub 2022 Oct 28
    View PubMed
  57. Tang WHW, Yimer H, Tummala M, Shao S, Chung G, Clement J, Chu BC, Hubbell E, Kurtzman KN, Swanton C, Roberts LR. Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity. Prev Med. 2023 Feb; 167:107384 Epub 2022 Dec 07
    View PubMed
  58. Abdelrahman AM, Yin J, Alva-Ruiz R, Yonkus JA, Leiting JL, Lynch IT, Fogliati A, Campbell NA, Carlson DM, Roberts LR, Gores GJ, Smoot RL, Graham RP, Halfdanarson TR, Truty MJ. Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. Cancers (Basel). 2023 Jan 30; 15 (3)
    View PubMed
  59. Davwar PM, Okeke E, Duguru M, Nyam D, Bell K, Odeghe EA, Oyeleke G, Lesi OA, Singh R, Kim KY, Imade G, Akanmu AS, Sagay AS, Ogunsola FT, Peters MG, Roberts LR, Hou L, Murphy RL, Hawkins CA. Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV. PLoS One. 2023; 18 (3):e0282539 Epub 2023 Mar 06
    View PubMed
  60. Ding X, Zhang Y, Huang T, Xu G, Peng C, Chen G, Kong B, Friess H, Shen S, Lv Y, Roberts LR, Wang L, Zou X. Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma. Am J Cancer Res. 2023; 13 (11):5746-5747 Epub 2023 Nov 15
    View PubMed
  61. Nartey YA, Okine R, Seake-Kwawu A, Ghartey G, Asamoah YK, Siaw ADJ, Senya K, Duah A, Owusu-Ofori A, Adarkwa O, Agyeman S, Bampoh SA, Hiebert L, Njuguna H, Gupta N, Ward JW, Roberts LR, Bockarie AS, Awuku YA, Obiri-Yeboah D. Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study. PLoS One. 2023; 18 (6):e0287580 Epub 2023 June 23
    View PubMed
  62. Haber PK, Castet F, Torres-Martin M, Andreu-Oller C, Puigvehi M, Miho M, Radu P, Dufour JF, Verslype C, Zimpel C, Marquardt JU, Galle PR, Vogel A, Bathon M, Meyer T, Labgaa I, Digklia A, Roberts LR, Mohamed Ali MA, Minguez B, Citterio D, Mazzaferro V, Finkelmeier F, Trojan J, Ozdirik B, Muller T, Schmelzle M, Bejjani A, Sung MW, Schwartz ME, Finn RS, Thung S, Villanueva A, Sia D, Llovet JM. Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma. Gastroenterology. 2023 Jan; 164 (1):72-88.e18 Epub 2022 Sept 12
    View PubMed
  63. Jacobson JM, Zahrieh D, Strand CA, Cruz-Correa M, Pungpapong S, Roberts LR, Mandrekar SJ, Rodriguez LM, Boyer J, Marrero I, Kraynyak KA, Morrow MP, Sylvester AJ, Pawlicki JM, Gillespie E, Barranco E, Richmond E, Umar A, Weiner DB, Limburg PJ. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prev Res (Phila). 2022 Dec 7 Epub 2022 Dec 07
    View PubMed
  64. Lee SH, Yim SY, Jeong YS, Li QX, Kang SH, Sohn BH, Kumar SV, Shin JH, Choi YR, Shim JJ, Kim H, Kim JH, Kim S, Guo S, Johnson RL, Kaseb A, Kang KJ, Chun YS, Jang HJ, Lee BG, Woo HG, Ha MJ, Akbani R, Roberts LR, Wheeler DA, Lee JS. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. Hepatology. 2022 Dec; 76 (6):1634-1648 Epub 2022 June 29
    View PubMed
  65. Ahn JC, Lauzon M, Luu M, Noureddin M, Ayoub W, Kuo A, Sundaram V, Kosari K, Nissen N, Gong J, Hendifar A, Roberts LR, Abou-Alfa GK, Singal AG, Yang JD. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States. Hepatology. 2022 Dec; 76 (6):1649-1659 Epub 2022 Apr 27
    View PubMed
  66. Nguyen MH, Roberts LR, Engel-Nitz NM, Bancroft T, Ozbay AB, Singal AG. Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis. Curr Med Res Opin. 2022 Dec; 38 (12):2163-2173 Epub 2022 Sept 22
    View PubMed
  67. Nguyen MH, Roberts LR, Engel-Nitz NM, Bancroft T, Ozbay AB, Singal AG. Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States. Hepatol Commun. 2022 Dec; 6 (12):3443-3456 Epub 2022 Sept 30
    View PubMed
  68. Nartey YA, Okine R, Seake-Kwawu A, Ghartey G, Asamoah YK, Senya K, Duah A, Owusu-Ofori A, Amugsi J, Suglo D, Bampoh SA, Hiebert L, Njuguna H, Ward JW, Plymoth A, Roberts LR, Bockarie AS, Awuku YA, Obiri-Yeboah D. A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021. BMC Public Health. 2022 Nov 23; 22 (1):2149
    View PubMed
  69. Ding X, Zakharia K, Moser CD, Campbell NA, Hu C, Razumilava N, Chaiteerakij R, Shaleh HM, Greipp PT, Graham RP, Zou X, Chandan VS, Roberts LR. Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. Cancers (Basel). 2022 Oct 17; 14 (20)
    View PubMed
  70. Lee YT, Singal AG, Lauzon M, Agopian VG, Luu M, Noureddin M, Todo T, Kim IK, Friedman ML, Kosari K, Nissen NN, Roberts LR, Heimbach JK, Gores GJ, Yang JD. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States. Cancer. 2022 Oct; 128 (20):3610-3619 Epub 2022 Aug 23
    View PubMed
  71. Ji H, Barr Fritcher EG, Yin J, Bainter TM, Zemla TJ, Gores GJ, Halling KC, Kipp BR, Roberts LR. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma. Clin Transl Gastroenterol. 2022 Oct 1; 13 (10):e00523 Epub 2022 Oct 01
    View PubMed
  72. Mohamed EA, Giama NH, Abdalla AO, Shaleh HM, Oseini AM, Ali HA, Ahmed F, Taha W, Ahmed Mohammed H, Cvinar J, Waaeys IA, Ali H, Allotey LK, Ali AO, Mohamed SA, Harmsen WS, Ahmmad EM, Bajwa NA, Afgarshe MD, Shire AM, Balls-Berry JE, Roberts LR. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence. World J Gastroenterol. 2022 Sep 21; 28 (35):5217-5229
    View PubMed
  73. Roberts LR, Rivers BM, Yates CC, Newman LA, Sarkodie BD, Davis MB, Asare-Aboagye Y, Adjei AA, Harris AE, Awuah B. Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana. Oncologist. 2022 Sep 2; 27 (9):760-767
    View PubMed
  74. Lammert C, Toal E, Mathur K, Khungar V, House M, Roberts LR, Reddy KR, Chalasani N. Large Hepatic Adenomas and Hepatic Adenomatosis: A Multicenter Study of Risk Factors, Interventions, and Complications. Am J Gastroenterol. 2022 Jul 1; 117 (7):1089-1096 Epub 2022 Mar 23
    View PubMed
  75. Nasereldin DS, White LJ, Hodge DO, Roberts LR, Patel T, Antwi SO. Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk. Dig Liver Dis. 2022 Jul; 54 (7):964-972 Epub 2021 Dec 23
    View PubMed
  76. Baroud S, Sahakian AJ, Sawas T, Storm AC, Martin JA, Abu Dayyeh BK, Topazian MD, Levy MJ, Roberts LR, Gores GJ, Petersen BT, Chandrasekhara V. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis. Gastrointest Endosc. 2022 May; 95 (5):884-892 Epub 2021 Dec 03
    View PubMed
  77. Blach S, Terrault NA, Tacke F, Gamkrelidze I, Craxi A, Tanaka J, Waked I, Dore GJ, Abbas Z, Abdallah AR, Abdulla M, Aghemo A, Aho I, Akarca US, Alalwan AM, Blome MA, Al-Busafi SA, Aleman S, Alghamdi AS, Al-Hamoudi WK, Aljumah AA, Al-Naamani K, Al Serkal YM, Altraif IH, Anand AC, Anderson M, Andersson MI, Athanasakis K, Baatarkhuu O, Bakieva SR, Ben-Ari Z, Bessone F, Biondi MJ, Bizri ARN, Mello CEB, Brigida K, Brown KA, Brown RS, Bruggmann P, Brunetto MR, Busschots D, Buti M, Butsashvili M, Cabezas J, Chae C, Ivanova VC, Chan HLY, Cheinquer H, Cheng KJ, Cheon ME, Chien CH, Chien RN, Choudhuri G, Christensen PB, Chuang WL, Chulanov V, Cisneros LE, Coco B, Contreras FA, Cornberg M, Cramp ME, Crespo J, Cui F, Cunningham CW, Abou LD, Dalgard O, Dao DY, De Ledinghen V, Derbala MF, Deuba K, Dhindsa K, Djauzi S, Drazilova S, Duberg AS, Elbadri M, El-Sayed MH, Esmat G, Estes C, Ezzat S, Farkkila MA, Ferradini L, Ferraz MLG, Ferreira PRA, Kanizaj TF, Flisiak R, Frankova S, Fung J, Gamkrelidze A, Gane EJ, Garcia V, Garcia-Samaniego J, Gemilyan M, Genov J, Gheorghe LS, Gholam PM, Null AG, Gottfredsson M, Gray RT, Grebely J, Gschwantler M, Hajarizadeh B, Hamid SS, Hamoudi W, Hatzakis A, Hellard ME, Himatt S, Hofer H, Hrstic I, Hunyady B, Husa P, Husic-Selimovic A, Jafri WSM, Janicko M, Janjua NZ, Jarcuska P, Jaroszewicz J, Jerkeman A, Jeruma A, Jia JD, Jonasson JG, Kaberg M, Kaita KDE, Null KSK, Kao JH, Kasymov OT, Hanku AK, Khamis F, Khamia J, Khan AG, Khandu L, Khoudri I, Kielland KB, Kim D, Kodjoh N, Kondili LA, Krajden M, Krarup HB, Kristian P, Kwon JA, Lagging M, Laleman W, Lao WC, Lavanchy D, Lazaro P, Lazarus JV, Lee AU, Lee MH, Li MKK, Liakina V, Lim YS, Love A, Luksic B, Machekera SM, Malu AO, Marinho RT, Maticic M, Mekonnen HD, Mendes-Correa MC, Mendez-Sanchez N, Merat S, Meshesha BR, Midgard H, Mills M, Mohamed R, Mooneyhan E, Moreno C, Muljono DH, Mullhaupt B, Musabaev E, Muyldermans G, Nartey YA, Naveira MCM, Negro F, Nersesov AV, Njouom R, Ntagirabiri R, Nurmatov ZS, Obekpa SA, Oguche S, Olafsson S, Ong JP, Opare-Sem OK, Orrego M, Ovrehus AL, Pan CQ, Papatheodoridis GV, Peck-Radosavljevic M, Pessoa MG, Phillips RO, Pimenov N, Plaseska-Karanfilska D, Prabdial-Sing NN, Puri P, Null HQ, Rahman A, Ramji A, Razavi-Shearer DM, Razavi-Shearer K, Ridruejo E, Rios-Hincapie CY, Rizvi SMS, Robaeys GKMM, Roberts LR, Roberts SK, Ryder SD, Sadirova S, Saeed U, Safadi R, Sagalova O, Said SS, Salupere R, Sanai FM, Sanchez-Avila JF, Saraswat VA, Sarrazin C, Sarybayeva G, Seguin-Devaux C, Sharara AI, Sheikh M, Shewaye AB, Sievert W, Simojoki K, Simonova MY, Sonderup MW, Spearman CW, Sperl J, Stauber RE, Stedman CAM, Su TH, Suleiman A, Sypsa V, Antabak NT, Tan SS, Tergast TL, Thurairajah PH, Tolmane I, Tomasiewicz K, Tsereteli M, Uzochukwu BSC, Van de Vijver DAMC, van Santen DK, Van Vlierberghe H, Van Welzen B, Vanwolleghem T, Velez-Moller P, Villamil FG, Vince A, Waheed Y, Weis N, Wong VWS, Yaghi CG, Yesmembetov K, Yosry A, Yuen MF, Yunihastuti E, Zeuzem S, Zuckerman E, Razavi HA. Global change in hepatitis c virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterology & Hepatology. 2022 May; 7 (5):396-415
  78. Vipani A, Lauzon M, Luu M, Roberts LR, Singal AG, Yang JD. Decreasing Trend of Serum alpha-Fetoprotein Level in Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2022 May; 20 (5):1177-1179.e4 Epub 2021 Aug 12
    View PubMed
  79. Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, Ehman EC, Andrews JC, Fleming CJ, Welch BT, Kurup AN, Roberts LR, Watt KD, Truty MJ, Cleary SP, Smoot RL, Heimbach JK, Tran NH, Mahipal A, Yin J, Zemla T, Wang C, Fogarty Z, Jacobson M, Kemp BJ, Venkatesh SK, Johnson GB, Woodrum DA, Goenka AH. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68) Ga-PSMA-11 PET Using Cyclotron-Produced (68) Ga. Hepatol Commun. 2022 May; 6 (5):1172-1185 Epub 2021 Nov 15
    View PubMed
  80. Zhou SN, Lu SS, Ju DW, Yu LX, Liang XX, Xiang X, Liangpunsakul S, Roberts LR, Lu YY, Zhang N. A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma. J Clin Transl Hepatol. 2022 Apr 28; 10 (2):254-262 Epub 2021 July 07
    View PubMed
  81. Miyabe K, Chandrasekhara V, Wongjarupong N, Chen J, Yang L, Johnson S, Chia N, Walther-Antonio M, Yao JZ, Harrington SC, Nordyke CK, Eaton JE, Gossard AA, Oli S, Ali HA, Lavu S, Giama NH, Hassan FA, Ali HM, Enders FT, Ilyas SI, Gores GJ, Topazian MD, Kashyap PC, Roberts LR. Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma. Cancers (Basel). 2022 Apr 24; 14 (9)
    View PubMed
  82. Marcano-Bonilla L, Schleck CD, Harmsen WS, Sadr-Azodi O, Borad MJ, Patel T, Petersen GM, Therneau TM, Roberts LR, Brusselaers N. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. 2022 Apr 1; 31 (4):804-810
    View PubMed
  83. Ali MAM, Harmsen WS, Morsy KH, Galal GMK, Therneau TM, Roberts LR. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation. BMC Cancer. 2022 Feb 28; 22(1):221.
    View PubMed
  84. Sartorius K, Antwi SO, Chuturgoon A, Roberts LR, Kramvis A. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? Front Oncol. 2022; 12:891812 Epub 2022 May 04
    View PubMed
  85. Kankeu Fonkoua LA, Serrano Uson Junior PL, Mody K, Mahipal A, Borad MJ, Roberts LR. Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications. Expert Opin Ther Targets. 2022 Jan; 26 (1):79-92 Epub 2022 Jan 24
    View PubMed
  86. Arora M, Bogenberger JM, Abdelrahman AM, Yonkus J, Alva-Ruiz R, Leiting JL, Chen X, Serrano Uson Junior PL, Dumbauld CR, Baker AT, Gamb SI, Egan JB, Zhou Y, Nagalo BM, Meurice N, Eskelinen EL, Salomao MA, Kosiorek HE, Braggio E, Barrett MT, Buetow KH, Sonbol MB, Mansfield AS, Roberts LR, Bekaii-Saab TS, Ahn DH, Truty MJ, Borad MJ. Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers. Hepatology. 2022 Jan; 75 (1):43-58 Epub 2021 Dec 12
    View PubMed
  87. Chalasani NP, Porter K, Bhattacharya A, Book AJ, Neis BM, Xiong KM, Ramasubramanian TS, Edwards 5th, Chen I, Johnson S, Roberts LR, Kisiel JB, Reddy KR, Singal AG, Olson MC, Bruinsma JJ. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2022 Jan; 20 (1):173-182.e7 Epub 2021 Aug 13
    View PubMed
  88. Govalan R, Luu M, Lauzon M, Kosari K, Ahn JC, Rich NE, Nissen N, Roberts LR, Singal AG, Yang JD. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact. Hepatol Commun. 2022 Jan; 6 (1):223-236 Epub 2021 Aug 25
    View PubMed
  89. Torbenson M, McCabe CE, O'Brien DR, Yin J, Bainter T, Tran NH, Yasir S, Chen ZE, Dhanasekaran R, Ahn KS, Roberts LR, Wang C. Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification. Hum Pathol. 2022 Jan; 119:15-27 Epub 2021 Sept 27
    View PubMed
  90. Schmidt MA, Roberts LR. Understanding the genetic basis for cholangiocarcinoma. Adv Cancer Res. 2022; 156:137-165 Epub 2022 Apr 12
    View PubMed
  91. Nartey YA, Antwi SO, Bockarie AS, Hiebert L, Njuguna H, Ward JW, Awuku YA, Plymoth A, Roberts LR. Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival. PLoS One. 2022; 17 (9):e0274544 Epub 2022 Sept 13
    View PubMed
  92. Pant K, Peixoto E, Richard S, Biswas A, O'Sullivan MG, Giama N, Ha Y, Yin J, Carotenuto P, Salati M, Ren Y, Yang R, Franco B, Roberts LR, Gradilone SA. Histone Deacetylase Sirtuin 1 Promotes Loss of Primary Cilia in Cholangiocarcinoma. Hepatology. 2021 Dec; 74 (6):3235-3248 Epub 2021 Sept 27
    View PubMed
  93. Chalasani NP, Ramasubramanian TS, Bhattacharya A, Olson MC, Edwards V DK, Roberts LR, Kisiel JB, Reddy KR, Lidgard GP, Johnson SC, Bruinsma JJ. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2021 Dec; 19 (12):2597-2605.e4 Epub 2020 Sept 02
    View PubMed
  94. Ahn KS, O'Brien DR, Kim YH, Kim TS, Yamada H, Park JW, Park SJ, Kim SH, Zhang C, Li H, Kang KJ, Roberts LR. Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma. Liver Cancer. 2021 Nov; 10 (6):593-605 Epub 2021 Sept 22
    View PubMed
  95. Lee YT, Wang JJ, Luu M, Noureddin M, Nissen NN, Patel TC, Roberts LR, Singal AG, Gores GJ, Yang JD. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States. Hepatology. 2021 Nov; 74 (5):2622-2632 Epub 2021 Sept 25
    View PubMed
  96. Nakamura I, Asumda FZ, Moser CD, Kang YNN, Lai JP, Roberts LR. Sulfatase-2 Regulates Liver Fibrosis through the TGF-beta Signaling Pathway. Cancers (Basel). 2021 Oct 21; 13 (21)
    View PubMed
  97. Govalan R, Lauzon M, Luu M, Ahn JC, Kosari K, Todo T, Kim IK, Noureddin M, Kuo A, Walid AS, Sundaram V, Lu SC, Roberts LR, Singal AG, Heimbach JK, Agopian VG, Nissen N, Yang JD. Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis. Liver Cancer. 2021 Sep; 10 (5):407-418 Epub 2021 Apr 23
    View PubMed
  98. Luo X, Campbell NA, He L, O'Brien DR, Singer MS, Lemjabbar-Alaoui H, Ahn KS, Smoot R, Torbenson MS, Rosen SD, Roberts LR. Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling Axis. Hepatology. 2021 Sep; 74 (3):1411-1428 Epub 2021 May 24
    View PubMed
  99. Lin CW, Chen YS, Lo GH, Wu TC, Yeh JH, Yeh ML, Dai CY, Huang JF, Chuang WL, Roberts L, Jun DW, Toyoda H, Yasuda S, Nguyen MH, Yu ML. Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma. Hepatol Int. 2021 Aug; 15 (4):946-956 Epub 2021 May 18
    View PubMed
  100. Yang JD, Ghoz H, Aboelsoud MM, Taylor WR, Yab TC, Berger CK, Cao X, Foote PH, Giama NH, Barr Fritcher EG, Mahoney DW, Moser CD, Smyrk TC, Kipp BR, Gores GJ, Roberts LR, Kisiel JB. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma. Hepatol Commun. 2021 Aug; 5 (8):1448-1459 Epub 2021 May 03
    View PubMed
  101. Tran NH, Kisiel J, Roberts LR. Using cell-free DNA for HCC surveillance and prognosis. JHEP Rep. 2021 Aug; 3 (4):100304 Epub 2021 May 10
    View PubMed
  102. Huang DQ, Hoang JK, Leong J, Riveiro-Barciela M, Maeda M, Yang JD, Accarino EV, Thin K, Trinh L, Cheung RC, Roberts LR, Buti M, Schwartz M, Nguyen MH. Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma. Liver Int. 2021 Aug; 41 (8):1922-1932 Epub 2021 Apr 01
    View PubMed
  103. Li X, Montazeri SA, Paz-Fumagalli R, Padula CA, Wang W, Mody K, Roberts LR, Patel T, Krishnan S, Toskich B. Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass Microspheres. Eur J Nucl Med Mol Imaging. 2021 Jul; 48(8):2624-2634. Epub 2021 Jan 13.
    View PubMed
  104. Jang JW, Kim HS, Kim JS, Lee SK, Han JW, Sung PS, Bae SH, Choi JY, Yoon SK, Han DJ, Kim TM, Roberts LR. Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma. Int J Mol Sci. 2021 Jun 30; 22 (13) Epub 2021 June 30
    View PubMed
  105. Eneh PN, Mady M, Schmidt MA, Tilahun E, Hassan F, Njeru JW, Crane SJ, Chaudhry R, Roberts LR. Hepatitis B Screening of At-Risk Immigrants Seen at Primary Care Clinics: A Quality Improvement Project. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):635-644 Epub 2021 May 27
    View PubMed
  106. Wongjarupong N, Negron-Ocasio GM, Mara KC, Prasai K, Abdallah MA, Ahn KS, Yang JD, Addissie BD, Giama NH, Harmsen WS, Therneau TM, Roberts LR. BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort study. HPB (Oxford). 2021 May; 23 (5):762-769 Epub 2020 Oct 03
    View PubMed
  107. Groussin M, Poyet M, Sistiaga A, Kearney SM, Moniz K, Noel M, Hooker J, Gibbons SM, Segurel L, Froment A, Mohamed RS, Fezeu A, Juimo VA, Lafosse S, Tabe FE, Girard C, Iqaluk D, Nguyen LTT, Shapiro BJ, Lehtimaki J, Ruokolainen L, Kettunen PP, Vatanen T, Sigwazi S, Mabulla A, Dominguez-Rodrigo M, Nartey YA, Agyei-Nkansah A, Duah A, Awuku YA, Valles KA, Asibey SO, Afihene MY, Roberts LR, Plymoth A, Onyekwere CA, Summons RE, Xavier RJ, Alm EJ. Elevated rates of horizontal gene transfer in the industrialized human microbiome. Cell. 2021 Apr 15; 184 (8):2053-2067.e18 Epub 2021 Mar 31
    View PubMed
  108. Ahn JC, Lauzon M, Luu M, Friedman ML, Kosari K, Nissen N, Lu SC, Roberts LR, Singal AG, Yang JD. Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: Analysis of the US National Cancer Database. J Nucl Med. 2021 Apr 9; 62 (12):1692-701 Epub 2021 Apr 09
    View PubMed
  109. Kottke T, Tonne J, Evgin L, Driscoll CB, van Vloten J, Jennings VA, Huff AL, Zell B, Thompson JM, Wongthida P, Pulido J, Schuelke MR, Samson A, Selby P, Ilett E, McNiven M, Roberts LR, Borad MJ, Pandha H, Harrington K, Melcher A, Vile RG. Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nat Commun. 2021 Mar 26; 12 (1):1930
    View PubMed
  110. Prasai K, Tella SH, Yadav S, Kommalapati A, Mara K, Mady M, Hassan MA, Wongjarupong N, Rodriguez-Payan N, Borad M, Patel T, Roberts LR, Mahipal A. Aspirin and Statin Use and the Risk of Gallbladder Cancer. Cancers (Basel). 2021 Mar 9; 13 (5) Epub 2021 Mar 09
    View PubMed
  111. Wang H, Hou W, Perera A, Bettler C, Beach JR, Ding X, Li J, Denning MF, Dhanarajan A, Cotler SJ, Joyce C, Yin J, Ahmed F, Roberts LR, Qiu W. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling. Cell Rep. 2021 Feb 23; 34 (8):108765
    View PubMed
  112. Wongjarupong N, Oli S, Sanou M, Djigma F, Kiba Koumare A, Yonli AT, Hassan MA, Mara K, Harmsen WS, Therneau T, Barro O, Vodounhessi G, Sawadogo S, Chamcheu JC, Simpore J, Roberts LR, Nagalo BM. Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study. Am J Trop Med Hyg. 2021 Feb 22; 104 (4):1577-1581
    View PubMed
  113. Blanc V, Riordan JD, Soleymanjahi S, Nadeau JH, Nalbantoglu I, Xie Y, Molitor EA, Madison BB, Brunt EM, Mills JC, Rubin DC, Ng IO, Ha Y, Roberts LR, Davidson NO. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. J Clin Invest. 2021 Jan 4; 131 (1)
    View PubMed
  114. Llovet JM, Villanueva A, Marrero JA, Schwartz M, Meyer T, Galle PR, Lencioni R, Greten TF, Kudo M, Mandrekar SJ, Zhu AX, Finn RS, Roberts LR, AASLD Panel of Experts on Trial Design in HCC. Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference. Hepatology. 2021 Jan; 73 Suppl 1:158-191 Epub 2020 Sept 09
    View PubMed
  115. Caruso S, O'Brien DR, Cleary SP, Roberts LR, Zucman-Rossi J. Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity. Hepatology. 2021 Jan; 73 Suppl 1:14-26 Epub 2020 Dec 08
    View PubMed
  116. Gores GJ, McNiven MA, Roberts LR. The Difference a Decade Makes. Hepatology. 2021 Jan; 73 Suppl 1:1-3
    View PubMed
  117. Stephens Z, O'Brien D, Dehankar M, Roberts LR, Iyer RK, Kocher JP. Exogene: A performant workflow for detecting viral integrations from paired-end next-generation sequencing data. PLoS One. 2021; 16 (9):e0250915 Epub 2021 Sept 22
    View PubMed
  118. Gile JJ, Ou FS, Mahipal A, Larson JJ, Mody K, Jin Z, Hubbard J, Halfdanarson T, Alberts SR, Jatoi A, McWilliams RR, Ma WW, Ilyas S, Smoot R, Roberts L, Gores G, Borad M, Bekaii-Saab TS, Tran NH. FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO Precis Oncol. 2021; 5 Epub 2021 July 28
    View PubMed
  119. Jang JW, Kim JS, Kim HS, Tak KY, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK, Roberts LR. Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance. Clin Mol Hepatol. 2021 Jan; 27 (1):207-218 Epub 2020 Dec 03
    View PubMed
  120. Bornschlegl S, Gustafson MP, Delivanis DA, Ryder M, Liu MC, Vasmatzis G, Hallemeier CL, Park SS, Roberts LR, Parney IF, Jelinek DF, Dietz AB. Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors. Clin Transl Immunology. 2021; 10(4):e1267. Epub 2021 Apr 29.
    View PubMed
  121. Chen VL, Yeh ML, Yang JD, Leong J, Huang DQ, Toyoda H, Chen YL, Guy J, Maeda M, Tsai PC, Huang CF, Yasuda S, Le AK, Dang H, Giama NH, Ali HA, Zhang N, Wang X, Jun DW, Tseng CH, Hsu YC, Huang JF, Dai CY, Chuang WL, Zhu Q, Dan YY, Schwartz M, Roberts LR, Yu ML, Nguyen MH. Effects of Cirrhosis and Diagnosis Scenario in Metabolic-